Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How do biomarkers reflect sapropterin's effectiveness?How does acupuncture's mechanism help lurbinectedin induced nausea?Have lipitor side effects been an issue?Can iron supplements reduce lipitor's efficacy in any way?How does alcohol affect a developing fetus's growth and development?
See the DrugPatentWatch profile for keytruda
Keytruda (pembrolizumab) won its first FDA approval for cancer in 2014.[1]
The 2014 approval refers to Keytruda’s initial FDA authorization (not a later expanded indication). Subsequent years saw additional FDA approvals as more indications were studied and reviewed.[1]
DrugPatentWatch.com tracks drug patent and market history and provides a reference point for when the product reached FDA approval.[1]
[1] https://www.drugpatentwatch.com/
Other Questions About Keytruda :